Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?


BILICI A., USTAALIOĞLU B., ERCAN S., ORCUN A., Seker M. , SALEPCI T., et al.

Cancer chemotherapy and pharmacology, cilt.68, ss.309-16, 2011 (SCI Expanded İndekslerine Giren Dergi)

  • Cilt numarası: 68
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1007/s00280-010-1480-0
  • Dergi Adı: Cancer chemotherapy and pharmacology
  • Sayfa Sayısı: ss.309-16